课题基金 / 基金详情

Analysis of the role of STAT6 signaling in the induction of CHS

Analysis of the role of STAT6 signaling in the induction of CHS
STAT6信号在CHS诱导中的作用分析
批准号:
10670781
负责人:
YOKOZEKI Hiroo
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

YOKOZEKI Hiroo的其他基金

相似基金

相关文献

中文摘要
翻译
接触性超敏反应(CHS)被认为主要与辅助性t细胞(Th) 1的激活有关。然而,也有证据表明Th2细胞或Th2细胞因子在CHS的发展中起作用。为了分析Th2细胞因子、IL-4和IL-13的功能贡献,将STAT6缺陷(STAT6-/-)和野生型对照(wt)小鼠(C57BL/6)分别用5% TNCB、0.5% DNFB或5% Oxa接触致敏,然后观察任何皮肤反应。与wt小鼠相比,STAT6-/-小鼠的耳部肿胀明显减少,峰值反应延迟。组织学分析显示,与wt小鼠相比,STAT6-/-小鼠皮肤中嗜酸性粒细胞和中性粒细胞的浸润在24小时后显著减少。STAT6-/-小鼠的皮肤组织和TNBS修饰脾细胞刺激的T细胞上清液中Th2细胞因子(IL-4、IL-5)的表达以及攻毒后的IgE和IgG1反应也显著降低,而IFN γ的表达在STAT6-/-小鼠和wt小鼠中相同。此外,过继转移实验显示,注射致敏wt小鼠的淋巴结细胞后,STAT6-/-小鼠诱导了接触性超敏反应。我们的数据表明,STAT6信号在CHS的i诱导阶段起着关键作用。
英文摘要
Contact hypersensitivity (CHS) is thought to be mainly associated with the activation of T-helper (Th) 1 cells. However, there is also evidence that Th2 cells or Th2 cytokines play a role in the development of CHS.In order to analyze the functional contribution of Th2 cvtokines, IL-4 and IL-13, STAT6 deficient (STAT6-/-) and wild-type control (wt) mice (C57BL/6) were contact sensitized with 5% TNCB, 0.5 % DNFB or 5% Oxa, and then any skin reactions were examined. Ear swelling was significantly reduced with a delayed peak response in STAT6-/- mice as compared with wt mice.A histological analysis revealed that the infiltration of both eosinophils and neutrophils in the skin challenged after 24 h in STAT6-/- mice decreasead substantially in comparison with that in wt mice. The expression of Th2 cytokines (IL-4, IL-5 ) in TNCB-challenged skin tissues and the supernatants from T cells stimulated by TNBS -modified spleen cells as well as the IgE and IgG1 response after challenge were also profoundly reduced in STAT6-/- mice, whereas the expression of IFN γ was the same in STAT6-/- mice and wt mice after challenge. Furthermore, Adoptive transfer experiments revealed that STAT6-/- mice induced the contact hypersensitivity after injection of lymph node cells obtained from sensitized wt mice.Our data suggest that the STAT6 signal palys a critical role in the i nductionphase of CHS.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
横関博雄, 西岡清: "アレルギー"有ビ閣. 232 (1998)
横关宏夫、西冈清:“过敏”Yubikaku 232 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tokoyama K,Yokozeki H et al : "IL-4 inhibitotle migration of human Langerhas cells through the down regulator of TNF-α recaptor II expression"J Invest Dermatol. 113. 541-546 (1999)
Tokoyama K、Yokozeki H 等人:“IL-4 通过 TNF-α 受体 II 表达的下调调节剂抑制人朗格哈斯细胞的迁移”J Invest Dermatol. 113. 541-546 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokozeki, H, Ghoreishi M, Takagaw S. et al: "STAT6 is essential in the induction of contact hypersensitivity"J. Exp. Medicine. in press. (2000)
Yokozeki, H, Ghoreishi M, Takagaw S. 等人:“STAT6 在接触性超敏反应的诱导中至关重要”J.
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
横関博雄: "アトピー性皮膚炎:コンセンサスアップデイト"メディカルレビュー社. 285 (2000)
Hiroo Yokozeki:“特应性皮炎:共识更新”Medical Review Co., Ltd. 285 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Analysis and development of a pinpointed and novel treatment focused on basophils for untreated skin allergic diseases
    • 批准号:
      16K10124
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2016
    • 负责人:
      YOKOZEKI Hiroo
    • 依托单位:
    Analysis for the mechanism of prurigo reaction focusing on basophils
    • 批准号:
      22591218
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      YOKOZEKI Hiroo
    • 依托单位:
    Gene silencing of STAT6 with siRNA ameliorates contact hypersensitivity and allergic rhinitis
    • 批准号:
      19591297
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2007
    • 负责人:
      YOKOZEKI Hiroo
    • 依托单位:
    A trial of gene therapy for contact allergy and atopic dermatitis
    • 批准号:
      13670869
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      2001
    • 负责人:
      YOKOZEKI Hiroo
    • 依托单位:
    国内基金
    海外基金
    肠道菌群代谢产物SCFA调控Th1/Th2失衡在儿童过敏性鼻炎中的作用及益生菌靶向干预研究
    • 批准号:
      2026JJ82542
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      谢骏
    • 依托单位:
    肺滤泡成熟B细胞在哮喘Th2反应中的作用及机制探讨
    • 批准号:
      JCZRLH202600711
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于TSLP-OX40L/Th2通路探讨吸入性过敏原组分在儿童过敏性鼻炎中的致敏机制与临床应用
    • 批准号:
      2026JJ82154
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      罗伶俐
    • 依托单位:
    基于“金虚宜敛”理论探讨过敏煎经“共生菌-肠肺轴-Th1/Th2免疫失衡”途径防治哮喘的药效机制
    • 批准号:
      JCZRLH202600644
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: